A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers

BACKGROUND: Blockade of the vascular endothelial growth factor (VEGF) pathway shows evidence of activity in gastro-oesophageal (GE) and oesophageal cancer. We investigated the efficacy of sunitinib, a multikinase VEGF inhibitor, in patients with relapsed/refractory GE/oesophageal cancer. METHODS: Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Wu, C, Mikhail, S, Wei, L, Timmers, C, Tahiri, S, Neal, A, Walker, J, El-Dika, S, Blazer, M, Rock, J, Clark, D J, Yang, X, Chen, J L, Liu, J, Knopp, M V, Bekaii-Saab, T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4506385/
https://ncbi.nlm.nih.gov/pubmed/26151457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados